Company Filing History:
Years Active: 2024
Title: Skander Elleuche: Innovator in Microfluidic Technology
Introduction
Skander Elleuche is a notable inventor based in Hamburg, Germany. He has made significant contributions to the field of biotechnology, particularly in the area of microfluidics. His work focuses on enhancing the flow of cells through microfluidic channels, which is crucial for various applications in medical and research settings.
Latest Patents
Skander Elleuche holds a patent for "Non-specific nucleases from the genus for use in facilitating flow of cells through a microfluidic channel." This invention provides a composition that includes an isolated polypeptide with non-specific nuclease (NSN) activity. The polypeptide is designed to degrade nucleic acids and has a sequence identity of at least 70% to SEQ ID NO:2. The composition is effective at a solution temperature of about 4° C. and includes a cation complexing agent such as EDTA. Additionally, the composition is preferably formulated to have a neutral to basic pH. A kit comprising this composition and a method for its use are also disclosed in the patent.
Career Highlights
Skander Elleuche is currently employed at Miltenyi Biotec B.V. & Co. KG, a company renowned for its innovative solutions in the field of biotechnology. His work at Miltenyi Biotec has allowed him to further develop his ideas and contribute to advancements in cell flow technology.
Collaborations
Throughout his career, Skander has collaborated with talented individuals such as Sarah Schmitz and Stefan Miltenyi. These collaborations have fostered a creative environment that encourages innovation and the development of cutting-edge technologies.
Conclusion
Skander Elleuche is a prominent figure in the field of biotechnology, with a focus on microfluidic applications. His patent and work at Miltenyi Biotec highlight his commitment to advancing technology in this vital area. His contributions are paving the way for future innovations in cell flow and related technologies.